Boryung Corporation (003850.KS) has a MoatMap StockRank of 70/100 based on Quality (50/100), Value (49/100), and Momentum (52/100) factor scores. The current signal is BUY. Boryung Corporation, a South Korean biopharmaceutical company, aligns perfectly with the 'Moated Healthcare Innovation' theme. With a focus on specialty pharmaceuticals (e.g., cardiovascular, oncology), it likely possesses strong R&D pipelines and patent protection, offering durable moats and consistent earnings compounding. South Korea is identified as a 'Resilient EM' market, providing a stable domestic base and potential for regional expansion. This combination offers a defensive yet innovative growth story, potentially underappreciated by a market focused on broader healthcare sector pessimism.